An initiative supported by France 2030
Supported by the French National Research Agency (ANR) as part of the France 2030 program, NeuroDM aims to structure a network of excellence connecting hospital teams, researchers, and neuroscience MedTech stakeholders — from the initial research phases to clinical evaluation.
This initiative facilitates collaboration between clinicians, engineers, researchers, and biomedical companies to accelerate the transformation of technological innovations into concrete solutions for medical practice.
The NeuroDM process
Innovation support diagram — from the laboratory to clinical practice.
A university hospital network of excellence
NeuroDM federates several major neurosurgery centers in the Paris region, recognized for their clinical expertise and involvement in research:
Support for MedTech stakeholders
The network is aimed at all stakeholders involved in the development of medical technologies applied to neurosciences — MedTech start-ups, academic research teams, public or private laboratories, and medical device manufacturers.
The objective is to facilitate rigorous scientific and clinical evaluations, reduce uncertainties related to technological development, and accelerate the transition from innovation to clinical practice.
